mephentermine has been researched along with Mitral Valve Stenosis in 1 studies
Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
Mitral Valve Stenosis: Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BARRERA, F | 1 |
| REGALADO, GG | 1 |
| CHANGSUT, RL | 1 |
| DOMINGUEZ, JC | 1 |
1 other study available for mephentermine and Mitral Valve Stenosis
| Article | Year |
|---|---|
Cardiovascular-respiratory actions of mephentermine in mitral stenosis and its effects on pulmonary function in chronic pulmonary emphysema.
Topics: Cardiovascular System; Humans; Mephentermine; Mitral Valve Stenosis; Pulmonary Emphysema | 1961 |